January 23, 2024

#5 - Jason Foster: Driving Global Access to Life-Saving Therapies

Listen and subscribe on your favorite platform

This podcast episode features a conversation with Jason Foster, CEO of Ori Biotech, who discussed his varied career and insights into the biotech industry. Foster’s journey began in politics and healthcare policy in Washington, D.C., where he recognized the private sector’s crucial role in healthcare innovation. This realization spurred him to attend business school, leading to a significant role in a pharmaceutical company. His work there, marked by substantial growth, eventually took him to London to oversee European operations.

Foster’s career pivot to startups and healthcare investments reflects his passion for innovative healthcare solutions. He emphasizes the importance of assembling a strong team and the ability to solve complex problems in the startup environment. This approach is evident in his leadership at Ori Biotech, a company focused on revolutionizing cell and gene therapy manufacturing.

At Ori Biotech, Foster addresses the challenges of making advanced therapies accessible and affordable. He discusses the technological innovations and manufacturing strategies employed by Ori to streamline the production of these therapies. His vision is to democratize cell and gene therapies, making them available to a broader patient population.

The interview also delves into the broader implications of Ori Biotech’s work in the healthcare sector. Foster highlights the potential impact of their technology in transforming patient outcomes and reducing healthcare costs. He underscores the significance of collaboration between the private sector, academia, and regulatory bodies in advancing healthcare innovation.

About this Guest

Jason Foster

Jason is a dynamic leader with over 20 years of experience in the healthcare and technology sectors across the US, UK, and Europe. As the Chief Executive Officer of Ori Biotech, he spearheads the company’s efforts in revolutionizing cell and gene therapy manufacturing technology. Through digital transformation, Ori Biotech’s technology is automating and standardizing cell and gene therapy manufacturing. As a result, their system facilitates an innovative progression from pre-clinical stages to large-scale commercial production for therapy developers. The platform’s advanced hardware, intuitive software, and detailed analytical tools, is designed to boost production efficiency and reliability, all while simultaneously reducing costs. This advancement is pivotal in scaling up the production of critical therapies, facilitating their accessibility to a broader range of patients globally. Jason is also the host of the Ori Spotlight Podcast.

Explore Other Episodes

#11 – Dr. Neel Patel: Democratizing Medical Testing & Health Data

Dr. Neel Patel is the co founder and CEO of Zio Health, a medtech company based in London, UK. After a career of being a physician, he stated ZiO Health and worked towards a shared goal with his team: bringing hospital-grade lab testing to the point-of-use, enhancing accessibility to molecular testing and optimizing health and sickness prevention. More specifically, they have developed a point-of-care therapeutic drug monitoring device which measures medication concentration levels to improve drug treatment outcomes.
Dr. Patel is also a Partner at HealthTech Investors, an angel syndicate that invests in founders working on the best solutions in improving healthcare.

Read More »

#14 – Fabrice Paublant: Cooling the Future with Liquid Ventilation

Fabrice Paublant is the Chief Executive Officer at Orixha.

Orixha, a DeepTech company founded in 2018, emerged from a collaboration between researchers and clinicians at Sherbrooke University, EnvA, and INSERM. Dedicated to revolutionizing critical care, Orixha’s mission is to deliver the transformative benefits of liquid ventilation to patients worldwide. The company’s multidisciplinary team, blending expertise in engineering, pathophysiology, and pharmacology, has developed Vent2Cool—the first liquid ventilator designed for intensive care units. Published in leading scientific journals, their work highlights rapid therapeutic hypothermia and anti-inflammatory benefits, particularly for post-cardiac arrest syndrome and acute respiratory distress. 

Read More »

#8 – Aaron Emerson: Never Walking the Grey

Aaron is the Chief Executive Officer at CEGA Innovations located in Sioux Falls, SD. Before co founding CEGA, Aaron honed his expertise as a litigation attorney, specializing in complex commercial disputes and risk advisement. His rich background also extends into the academic realm, having delved into neuroscience at the University of South Dakota and Creighton University School of Medicine, kidney ischemia research at University Physicians, and cardiovascular studies at the University of Nebraska Medical Center.

Read More »

Join our newsletter for regular updates on the podcast, USD Discovery District, and medtech and life science related insights.

By submitting your email to subscribe, you agree to our Privacy Policy.

Proudly Sponsored By